Related Experiment Videos
Capillary refill test--a possible auxiliary diagnostic method in obliterative arteriosclerosis
T Sosa1, L Loncarić, S Boljesić
1Department of Vascular Surgery, University School of Medicine, Zagreb, Yugoslavia.
Cor Et Vasa
|January 1, 1991
Summary
Capillary refill index (CRI) effectively assesses lower extremity microcirculation in arteriosclerotic disease. Lower CRI values indicate more severe disease and improve after surgical intervention.
Area of Science:
- Vascular Medicine
- Dermatology
- Medical Diagnostics
Background:
- Arteriosclerotic disease significantly impairs lower extremity microcirculation.
- Assessing the severity of peripheral arterial disease is crucial for treatment decisions.
Purpose of the Study:
- To evaluate the utility of capillary refill time (CRT) and capillary refill index (CRI) in assessing lower extremity microcirculation in patients with arteriosclerotic disease.
- To establish pathological thresholds for CRI and correlate it with disease severity and treatment outcomes.
Main Methods:
- Measured CRT in 133 lower extremities of arteriosclerotic patients and 84 of healthy controls.
- Calculated CRI based on CRT measurements and defined pathological values (<0.80).
- Correlated CRI with ankle/arm Doppler index (AAI), walking distance, rest pain, and assessed changes post-surgery.
Main Results:
- CRI values below 0.80 were considered pathological.
- Significantly lower CRI values were observed in advanced arteriosclerotic disease (p < 0.01).
- A positive correlation (r=0.50) was found between AAI, walking distance, and CRI. Extremely low CRI (<0.55) indicated severe ischemia.
- Post-surgical treatment led to a significant increase in CRI (p < 0.01).
Conclusions:
- CRI is a valuable, non-invasive tool for evaluating microcirculatory dysfunction in arteriosclerotic lower extremities.
- CRI effectively reflects disease severity and predicts response to surgical intervention.
- A CRI threshold of 0.80 can identify pathological microcirculation in this patient group.